Atlas Trials

Glasdegib for Chronic Graft-Versus-Host Disease

Clinical trial NCT04111497 · TERMINATED

Trial details

NCT number
NCT04111497
Sponsor
Fred Hutchinson Cancer Center
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Chronic Graft Versus Host DiseaseFasciitis
Start date
2019-12-03
Primary completion
2023-08-23
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.